Join to access to all OVN content. Join for Free
How to Transition from MSL to MSL Leader
MSL to leadership personal development for managers effective time management strategies career advancement tips mentorship significance

How to Transition from MSL to MSL Leader


Share This Article


Summary

In this episode, Kathy Gann joins to discuss the transition from an MSL role to leadership positions. Kathy delves into personal development, goal setting, and the importance of lifelong learning and skill-building for aspiring managers. She shares insights on identifying the right time to step into management and the challenges that accompany such a transition. Kathy emphasizes effective time management, proactivity in career advancement, and the significance of mentorship. She also highlights strategies for gaining visibility through problem-solving and crafting a strategic leadership plan. The episode concludes with Kathy offering closing thoughts and acknowledgments.

Kathy Gann, Former Field MSL Director and MSL discusses how to transition from MSL to MSL Leader.

Kathy shares….

👉 How to position yourself for promotion

👉 What skills are mandatory and how to develop them

👉 How to prepare for a role in management

👉 The demands of being and MSL leader and what to expect

👉 The emotional side of being in charge of people

Click for Source
MSL to leadership, personal development for managers, effective time management strategies, career advancement tips, mentorship significance

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Promotability: Top 10 Tips for Landing Your Next Promotion
Partner Avatar MSL Talk: Tom Caravela, Bridget Rasmusson

Promotability: Top 10 Tips for Landing Your Next Promotion

Podcast
Diversity in Medical Affairs and the Power of Networking
Partner Avatar MSL Talk: Tom Caravela, Rachel Kennedy, Lashondra Taylor, Nirav Shah

Diversity in Medical Affairs and the Power of Networking

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Article
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
OVN Avatar Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Article
Clinical Educator Oncology Program Improves Adherence by 29%​
Partner Avatar iNIZIO

Clinical Educator Oncology Program Improves Adherence by 29%​

Explore OVN